 |
Seppo Mäkinen
b. 1952, M.Sc. Physical Chemistry Full-time occupation: Professional Board Member
Positions of trust:
- Bittium Corporation, Member of the Board 2015.
- Pathena S.A., Partner 2017.
- ValiRx Plc, Member of the Board 20132017, Advisor 2017.
- Evondos Oy, Member of the Board 2016.
- CBRA Genomics S.A., Member of the Board 2016.
- Neurotar Oy, Member of the Board 2015.
- MedGroup Oy, Member of the Board 2013.
- Ginolis Oy, Member of the Board 2011, Chairman of the Board 20112014.
Previous work history:
- Taikon Advisor, Managing Partner 20102016.
- Merieux Développement, Regional Partner, Nordics 20102016.
- Ventac Partners, Partner 20122016.
- Magnasense Technologies Oy, Member of the Board 20112015.
- Arcdia International Oy, Member of the Board 20112014.
- Balonco, Senior Advisor, owner 20122013.
- Mediracer Ltd., Chairman of the Board 20102013.
- RSP Systems, Member of the Board 20102011.
- Bio Fund Management Oy, Founding/ Managing Partner 19972010.
- Sitra, Director in Life Science 19871997.
- Millipore/ Waters, Sales & Marketing 19831987.
- State Institute of Agricultural Chemistry, Chemist 19801983.
- Served as a Chairman or Member of the Board in Egalet A/S, SpinX Inc., Chempaq, Profos AG, Ilochip A/S, Exiqon A/S, KSH-Productor Oy, Merlin Diagnostika GmbH, Primex ASA, Rumen Oy, Millimed Inc., BioPorto A/S, Wallac, Kone Instruments, Rados Technologies, MAP Medical Technologies, Pharming NV, Bio-Orbit, Labmaster Oy, Viable Bioproducts and Fluilogic Oy.
Holdings Dec. 31, 2017: Holds 2,871 shares in Bittium Corporation.
Independent as regards both the Company and its significant shareholders.
|